B
11.52
0.37 (3.32%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Biohaven Ltd. | 看涨 | 看跌 |
AIStockmoo 评分
0.0
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.00 |
|
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.96% |
| 机构持股比例 | 90.75% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Suvretta Capital Management, Llc | 31 Dec 2025 | 10,286,937 |
| Infinitum Asset Management, Llc | 31 Dec 2025 | 6,250,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 30.00 (TD Cowen, 160.42%) | 购买 |
| 中 | 22.00 (90.97%) | |
| 低 | 10.00 (HC Wainwright & Co., -13.19%) | 保留 |
| 平均值 | 21.00 (82.29%) | |
| 总计 | 3 购买, 1 保留 | |
| 平均价格@调整类型 | 10.34 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| TD Cowen | 11 Mar 2026 | 30.00 (160.42%) | 购买 | 10.46 |
| HC Wainwright & Co. | 04 Mar 2026 | 10.00 (-13.19%) | 保留 | 10.61 |
| 26 Dec 2025 | 11.00 (-4.51%) | 保留 | 11.15 | |
| RBC Capital | 03 Mar 2026 | 23.00 (99.65%) | 购买 | 10.67 |
| 21 Jan 2026 | 22.00 (90.97%) | 购买 | 12.87 | |
| Morgan Stanley | 06 Jan 2026 | 21.00 (82.29%) | 购买 | 9.62 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合